Zhejiang Dayang Biology Technology Co.,Ltd.
003017.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥1,517 | CN¥1,963 | CN¥1,612 | CN¥1,795 |
| - Cash | CN¥354 | CN¥382 | CN¥131 | CN¥132 |
| + Debt | CN¥358 | CN¥249 | CN¥282 | CN¥180 |
| Enterprise Value | CN¥1,522 | CN¥1,831 | CN¥1,763 | CN¥1,843 |
| Revenue | CN¥910 | CN¥919 | CN¥1,058 | CN¥783 |
| % Growth | -1% | -13.1% | 35.1% | – |
| Gross Profit | CN¥178 | CN¥166 | CN¥146 | CN¥152 |
| % Margin | 19.6% | 18.1% | 13.8% | 19.4% |
| EBITDA | CN¥147 | CN¥123 | CN¥123 | CN¥125 |
| % Margin | 16.2% | 13.4% | 11.6% | 16% |
| Net Income | CN¥64 | CN¥50 | CN¥81 | CN¥70 |
| % Margin | 7% | 5.4% | 7.6% | 8.9% |
| EPS Diluted | 0.78 | 0.62 | 0.99 | 1.16 |
| % Growth | 25.8% | -37.4% | -14.7% | – |
| Operating Cash Flow | CN¥66 | CN¥182 | CN¥92 | -CN¥35 |
| Capital Expenditures | -CN¥63 | -CN¥104 | -CN¥105 | -CN¥93 |
| Free Cash Flow | CN¥3 | CN¥79 | -CN¥13 | -CN¥129 |